Treace Medical Concepts, Inc.
TMCI
$7.47
-$0.23-2.99%
NASDAQ
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Net Income | -17.40M | -15.92M | -501.00K | -15.36M | -21.21M |
Total Depreciation and Amortization | 2.58M | 2.46M | 1.24M | 2.16M | 2.12M |
Total Amortization of Deferred Charges | 74.00K | 74.00K | 1.08M | 74.00K | 74.00K |
Total Other Non-Cash Items | 10.21M | 9.88M | 10.99M | 7.29M | 9.10M |
Change in Net Operating Assets | 1.49M | 7.70M | -17.01M | -6.00M | -3.98M |
Cash from Operations | -3.05M | 4.20M | -4.21M | -11.84M | -13.90M |
Capital Expenditure | -4.77M | -3.54M | -3.07M | -2.86M | -1.73M |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -- | -- | -- | -- | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | 1.51M | 1.65M | 6.50M | 8.63M | 24.16M |
Cash from Investing | -3.26M | -1.89M | 3.42M | 5.76M | 22.43M |
Total Debt Issued | 983.00K | -- | -- | -- | -- |
Total Debt Repaid | -98.00K | -- | -- | -- | -- |
Issuance of Common Stock | 116.00K | 119.00K | 57.00K | 8.00K | 311.00K |
Repurchase of Common Stock | -14.00K | -401.00K | -31.00K | 0.00 | 0.00 |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | -- | -- | -- | -- | -- |
Cash from Financing | 987.00K | -282.00K | 26.00K | 8.00K | 311.00K |
Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | -5.32M | 2.02M | -760.00K | -6.07M | 8.85M |